Bayer Group Consolidated Income Statements

 

 

Note

 

2014

 

2015

 

 

 

 

€ million

 

€ million

2014 figures restated

1

EBIT: earnings before financial result and taxes

Net sales

 

[7]

 

41,339

 

46,324

Cost of goods sold

 

 

 

(19,909)

 

(21,158)

Gross profit

 

 

 

21,430

 

25,166

 

 

 

 

 

 

 

Selling expenses

 

[8]

 

(10,669)

 

(12,367)

Research and development expenses

 

[9]

 

(3,537)

 

(4,281)

General administration expenses

 

 

 

(1,703)

 

(2,098)

Other operating income

 

[10]

 

710

 

1,110

Other operating expenses

 

[11]

 

(836)

 

(1,280)

EBIT1

 

 

 

5,395

 

6,250

 

 

 

 

 

 

 

Equity-method loss

 

[13.1]

 

(13)

 

(9)

Financial income

 

 

 

343

 

371

Financial expenses

 

 

 

(1,311)

 

(1,367)

Financial result

 

[13]

 

(981)

 

(1,005)

 

 

 

 

 

 

 

Income before income taxes

 

 

 

4,414

 

5,245

 

 

 

 

 

 

 

Income taxes

 

[14]

 

(1,071)

 

(1,227)

 

 

 

 

 

 

 

Income from continuing operations after income taxes

 

 

 

3,343

 

4,018

 

 

 

 

 

 

 

Income from discontinued operations after income taxes

 

[6.3]

 

100

 

80

 

 

 

 

 

 

 

Income after income taxes

 

 

 

3,443

 

4,098

of which attributable to noncontrolling interest

 

[15]

 

17

 

(12)

of which attributable to Bayer AG stockholders (net income)

 

 

 

3,426

 

4,110

 

 

 

 

 

 

 

 

 

 

 

 

Earnings per share

 

[16]

 

 

 

 

 

 

 

 

 

 

 

From continuing operations

 

[16]

 

 

 

 

Basic

 

 

 

4.02

 

4.87

Diluted

 

 

 

4.02

 

4.87

 

 

 

 

 

 

 

From discontinued operations

 

[16]

 

 

 

 

Basic

 

 

 

0.12

 

0.10

Diluted

 

 

 

0.12

 

0.10

 

 

 

 

 

 

 

From continuing and discontinued operations

 

[16]

 

 

 

 

Basic

 

 

 

4.14

 

4.97

Diluted

 

 

 

4.14

 

4.97